shutterstock_1179311575_vchal
Vchal / Shutterstock.com
30 September 2019AmericasSarah Morgan

Taiwanese firm accuses Pacific Biosciences of infringing sequencing tech

In its suit, filed at the US District Court for the District of Delaware on Thursday, September 26, PGI accused Pacific Biosciences of infringing US patent 7,767,441 through the sale of its nucleic acid sequencing platform Sequel System.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
2 November 2018   Gene-sequencing company Illumina has agreed to buy competitor Pacific Biosciences for $1.2 billion.
Asia
22 May 2020   Taiwanese biotechnology company Personal Genomics is using California’s Pacific Biosciences for patent infringement in China.

More on this story

Americas
2 November 2018   Gene-sequencing company Illumina has agreed to buy competitor Pacific Biosciences for $1.2 billion.
Asia
22 May 2020   Taiwanese biotechnology company Personal Genomics is using California’s Pacific Biosciences for patent infringement in China.

More on this story

Americas
2 November 2018   Gene-sequencing company Illumina has agreed to buy competitor Pacific Biosciences for $1.2 billion.
Asia
22 May 2020   Taiwanese biotechnology company Personal Genomics is using California’s Pacific Biosciences for patent infringement in China.